Tag:

Hypertension

Teladoc Expands Early Disease Detection, At-Home Tests For 90M+ Patients With $65M Deal Teladoc Expands Early Disease Detection, At-Home Tests For 90M+ Patients With $65M Deal
Teladoc Expands Early Disease Detection, At-Home Tests For 90M+ Patients With $65M Deal Teladoc Health is expanding its at-home healthcare offerings by purchasing a leading company in virtual preventive care. Teladoc announced on Wednesday, Feb. 5 that it will buy Catapult Health for $65 million. Headquartered in Purchase, New York, Teladoc helps more than 93 million people get virtual medical care and connects patients with doctors, nurses, and therapists. Catapult Health's platform called VirtualCheckup will be integrated into Teladoc's existing system, allowing patients to collect blood samples, check blood pressure, and complete other health screenings …
Pfizer Pills Recalled Due To Increased Cancer Risk Pfizer Pills Recalled Due To Increased Cancer Risk
Pfizer Pills Recalled Due To Increased Cancer Risk Pfizer has issued a recall for blood pressure pills that were distributed across the United States due to the presence of an organic compound it said could increase the risk of cancer. The five lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level, the Food and Drug Administration announced. "These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time," the FDA sai…
COVID-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says COVID-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says
Covid-19: These Factors May Determine Why Virus Spares Some, Kills Others, Report Says A new report has examined why the novel coronavirus (COVID-19) spares some and has proven deadly for others. Months into the outbreak of the virus across the globe that broke out stateside in mid-March, scientists continue to investigate COVID-19 to determine how it chooses its victims. According to The Washington Post report, “the research remains provisional or ambiguous, and for now scientists can’t do much better than say that COVID-19 is more likely to be worse for older people — often described as over the age of 60 — and for those with chronic conditions such as …